monitoring and evolution of field gumboro disease pressure after … · monitoring and evolution of...

41
Monitoring and evolution of field Gumboro disease pressure after continuos vaccination with an Immune-Complex Gumboro disease vaccine CEVA POULTRY VACCINOLOGIST SUMMIT Pablo Catalá Gregori DVM, PhD, Dipl. ECPVS CECAV [email protected]

Upload: others

Post on 24-Jan-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

  • Monitoring and evolution of field Gumboro disease pressure after continuos vaccination with an Immune-Complex Gumboro disease

    vaccine

    CEVA POULTRY VACCINOLOGIST SUMMIT

    Pablo Catalá Gregori

    DVM, PhD, Dipl. ECPVS

    CECAV – [email protected]

    javascript:self.close()

  • 2014 2

    1. Introduction

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • 2014 3

    1. Introduction

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • Introduction

    2014 4

    1. Introduction

    CECAV

    IBD status SPAIN

    In ovo vaccination

    Descriptive results

    Monitoring serological response

    Detect IBVD strain

    Alternative vaccination

  • Introduction

    2014 5

    1. Introduction

    CECAV

    IBD status SPAIN

    In ovo vaccination

    Descriptive results

    Monitoring serological response

    Detect IBVD strain

    Alternative vaccination

  • Introduction

    2014 6

    CECAV: POULTRY QUALITY AND ANIMAL NUTRITION CENTER OF COMUNIDAD VALENCIANA

    Non-profit, private and public service

    Laboratory (100.000) + training (1.000)

    Meat, Egg, Feed, Slautherhouse

    Dep: Microbiology, Serology, Chemical, Other

    CEVA collaboration

    62nd Western Poultry Disease Conference - USA

  • Introduction

    2014 7

    1. Introduction

    CECAV

    IBD status SPAIN

    In ovo vaccination

    Descriptive results

    Monitoring serological response

    Detect IBVD strain

    Alternative vaccination

  • Introduction

    2014 8

    1. Introduction

    CECAV

    IBD status SPAIN

    In ovo vaccination

    Descriptive results

    Monitoring serological response

    Detect IBVD strain

    Alternative vaccination

  • Introduction

    2014 9

    IBD status in SPAIN (CRESA)

    New Genotype since 2008

    + endemic vvIBD

  • Introduction

    2014 10

    IBD status in SPAIN (CRESA)

    New Genotype since 2008

    + endemic vvIBD

    *CESAC:

    2012 (27): 1 vvIBD

    2013 (32): 9 vvIBD (7 broiler; 2 layer)

  • Introduction

    2014 11

    IBD status in SPAIN (CRESA)

    Endemic vvIBD

    New Genotype:

    Unspecific symptomatology

    Macro: Bursa atrophy

    Micro: Lymphocyte B loss

  • Introduction

    2014 12

    1. Introduction

    CECAV

    IBD status SPAIN

    In ovo vaccination

    Descriptive results

    Monitoring serological response

    Detect IBVD strain

    Alternative vaccination

  • Introduction

    2014 13

    1. Introduction

    CECAV

    IBD status SPAIN

    In ovo vaccination

    Descriptive results

    Monitoring serological response

    Detect IBVD strain

    Alternative vaccination

  • Introduction

    2014 14

    In ovo vaccination

    Vaccines

    Conventional (water) Live attenuated

    Vector-based (in ovo; SC)

    Immune-complex (in ovo; SC)

    IBDV

  • 2014 15

    1. Introduction

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • 2014 16

    1. Introduction

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • OBJECTIVE

    2014 17

    1. Monitor serological response

    2. Detect IBDV strain

    • After In ovo single vaccination with Immune-complexvaccine

    • After Alternative

    In ovo single vaccination with Immune-complexvaccine / conventional live vaccination

    In ovo single vaccination with Immune-complexvaccine / vector based

  • 2014 18

    1. Introduction

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • 2014 19

    1. Introduction

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • Material and Methods

    2014 20

    • >5 years (2009-2014)

    • Spain

    • >3.500 Broiler Flocks; 8/15 serum per flock; >35.000 samples

    • In ovo single vaccination Cevac TRANSMUNE® d18

    • Sampling ≥26d (at farm or slaughterhouse)

    Serum – ELISA (Biochek) (SERAVIAN + CECAV)

    Random Bursa – RT- PCR+Sequencing; >200 samples; (CRESA + CESAC)

  • 2014 21

    1. Introduction

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • 2014 22

    1. Introduction

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • Results

    2014 23

    R² = 0,9242

    0

    1000

    2000

    3000

    4000

    5000

    6000

    7000

    8000

    29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53

    Me

    an E

    LISA

    GM

    TIT

    ER

    Age (Days)

    Fig. 1. ELISA GM titers in Vaccinated Broilers with an Immune-Complex IBD Vaccine

    (2009 - 2014; 3.781 flocks)

    2009-2014

    Trend (Polynomial)

  • Results

    2014 24

    R² = 0,9242

    0

    1000

    2000

    3000

    4000

    5000

    6000

    7000

    8000

    29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53

    Me

    an E

    LISA

    GM

    TIT

    ER

    Age (Days)

    Fig. 1. ELISA GM titers in Vaccinated Broilers with an Immune-Complex IBD Vaccine

    (2009 - 2014; 3.781 flocks)

    2009-2014

    Trend (Polynomial)

  • 0

    20

    40

    60

    80

    100

    120

    140

    160

    180

    200

    29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 D

    Year 2009

    Year 2010

    Year 2011

    Year 2012

    Year 2013

    Year 2014*

    Fig. 2. Serological Coefficient of Variation in Vaccinated Broilers with an Immune -Complex IBD Vaccine (2009 - 2014)

    Days of Age

    Co

    eff

    icie

    nt

    of

    Var

    iati

    on

    (%

    )Results

    2014 25

    ≥2012; ≥40d;

  • Results

    2014 26

    ≥2012; ≥40d;

  • 0

    20

    40

    60

    80

    100

    120

    140

    2012 2013 2014

    CU-1WT

    GM 97

    vvIBD

    D 78

    CH 80

    No secuenciable

    Atenuada

    W 2512

    Results

    2014 27

    Fig. 3. Bursa IBDV strain sequence results (2012 - 2014)

    W&TRM 76,2%

    N=109 N=116 N=18*

    W&TRM 77,8%*W&TRM 81,0%

    W 84,4% W 81,0% W 88,9%

  • Alternative vaccination

    2014 28

    CASE 1

    0

    2000

    4000

    6000

    8000

    10000

    12000

    14000

    16000

    0,00

    20,00

    40,00

    60,00

    80,00

    100,00

    120,00

    140,00

    05

    /03

    /20

    12

    05

    /03

    /20

    12

    05

    /03

    /20

    12

    21

    /03

    /20

    12

    28

    /03

    /20

    12

    28

    /03

    /20

    12

    18

    /04

    /20

    12

    18

    /04

    /20

    12

    18

    /04

    /20

    12

    24

    /04

    /20

    12

    02

    /05

    /20

    12

    02

    /05

    /20

    12

    02

    /05

    /20

    12

    02

    /05

    /20

    12

    02

    /05

    /20

    12

    15

    /05

    /20

    12

    15

    /05

    /20

    12

    07

    /06

    /20

    12

    07

    /06

    /20

    12

    25

    /06

    /20

    12

    25

    /06

    /20

    12

    27

    /06

    /20

    12

    27

    /06

    /20

    12

    06

    /07

    /20

    12

    13

    /07

    /20

    12

    28

    /08

    /20

    12

    28

    /08

    /20

    12

    11

    /09

    /20

    12

    11

    /09

    /20

    12

    20

    /09

    /20

    12

    20

    /09

    /20

    12

    04

    /10

    /20

    12

    04

    /10

    /20

    12

    04

    /10

    /20

    12

    04

    /10

    /20

    12

    21

    /11

    /20

    12

    21

    /11

    /20

    12

    29

    /11

    /20

    12

    29

    /11

    /20

    12

    IBD titer & %CV(Mar - Nov 2012; 78 flocks)

    Título Medio %CV

    Cambio pauta vac IBD

    Immunocomplex Live

  • Alternative vaccination

    2014 29

    CASE 2

    0

    2000

    4000

    6000

    8000

    10000

    12000

    14000

    16000

    0

    20

    40

    60

    80

    100

    120

    140

    160

    03

    /07

    /20

    12

    04

    /07

    /20

    12

    05

    /07

    /20

    12

    12

    /07

    /20

    12

    18

    /07

    /20

    12

    24

    /07

    /20

    12

    25

    /07

    /20

    12

    01

    /08

    /20

    12

    01

    /08

    /20

    12

    30

    /07

    /20

    12

    30

    /07

    /20

    12

    01

    /08

    /20

    12

    02

    /08

    /20

    12

    06

    /08

    /20

    12

    20

    /08

    /20

    12

    09

    /08

    /20

    12

    14

    /08

    /20

    12

    14

    /08

    /20

    12

    16

    /08

    /20

    12

    20

    /08

    /20

    12

    20

    /08

    /20

    12

    21

    /08

    /20

    12

    22

    /08

    /20

    12

    05

    /09

    /20

    12

    04

    /09

    /20

    12

    04

    /09

    /20

    12

    10

    /09

    /20

    12

    11

    /09

    /20

    12

    17

    /09

    /20

    12

    17

    /09

    /20

    12

    25

    /04

    /20

    13

    25

    /04

    /20

    13

    19

    /09

    /20

    13

    19

    /09

    /20

    13

    02

    /10

    /20

    13

    17

    /10

    /20

    13

    17

    /10

    /20

    13

    02

    /10

    /20

    13

    02

    /10

    /20

    13

    02

    /10

    /20

    13

    02

    /10

    /20

    13

    02

    /10

    /20

    13

    02

    /10

    /20

    13

    19

    /11

    /20

    13

    03

    /12

    /20

    13

    12

    /12

    /20

    13

    IBD titer & %CV(Jul - Sept 2012; 30 flocks Apr - Dec 2013; 16 flocks)

    Título Medio %CV

    Cambio pauta vac IBD

    Immunocomplex Live

  • Alternative vaccination

    2014 30

    CASE 3

    0

    2000

    4000

    6000

    8000

    10000

    12000

    14000

    16000

    0

    20

    40

    60

    80

    100

    120

    140

    160

    180

    28

    /03

    /20

    12

    03

    /04

    /20

    12

    03

    /04

    /20

    12

    18

    /04

    /20

    12

    18

    /04

    /20

    12

    24

    /04

    /20

    12

    08

    /05

    /20

    12

    08

    /05

    /20

    12

    15

    /05

    /20

    12

    23

    /05

    /20

    12

    07

    /06

    /20

    12

    13

    /06

    /20

    12

    25

    /06

    /20

    12

    27

    /06

    /20

    12

    06

    /07

    /20

    12

    06

    /07

    /20

    12

    24

    /07

    /20

    12

    08

    /08

    /20

    12

    08

    /08

    /20

    12

    26

    /09

    /20

    12

    26

    /09

    /20

    12

    04

    /10

    /20

    12

    15

    /10

    /20

    12

    30

    /10

    /20

    12

    30

    /10

    /20

    12

    12

    /12

    /20

    12

    12

    /12

    /20

    12

    15

    /01

    /20

    13

    23

    /01

    /20

    13

    31

    /01

    /20

    13

    13

    /02

    /20

    13

    20

    /02

    /20

    13

    07

    /03

    /20

    13

    07

    /03

    /20

    13

    13

    /03

    /20

    13

    26

    /03

    /20

    13

    18

    /04

    /20

    13

    18

    /04

    /20

    13

    25

    /04

    /20

    13

    02

    /05

    /20

    13

    06

    /05

    /20

    13

    29

    /04

    /20

    13

    14

    /05

    /20

    13

    14

    /03

    /20

    14

    21

    /03

    /20

    14

    01

    /04

    /20

    14

    01

    /04

    /20

    14

    IBD titer & %CV(Mar - May 2012; 157 flocks)(Jan - May 2013; 97 flocks)

    (Mar - Apr 2014; 112 flocks)

    Título Medio %CV

    Cambio pautavac IBD

    Immunocomplex Vector - based

  • Results

    2014 31

    1. Serological response

    GM titer: Rising trend as the broiler grow (stab. 6,000&34d)

    Single vaccination – uniform flock immunization

    %CV: Downward trend over the years (under 40% since 2012 from 40d)

    Improvement of the proper hatchery vaccination

    2. IBDV strain

    Winterfield 2512

    Vaccine presence >75% & TRM

    3. Alternative vaccination

    Impaired %CV

  • 2014 32

    1. Introduction

    1. Broiler production EU-SPAIN

    2. IBD status SPAIN

    3. In ovo vaccination

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • 2014 33

    1. Introduction

    1. Broiler production EU-SPAIN

    2. IBD status SPAIN

    3. In ovo vaccination

    2. Objective

    3. Material and Methods

    4. Results

    5. Geographical Monitoring Tool

  • Geographical Monitoring Tool

    2014 34

    Geographical Monitoring IBDV response to single vaccination:

    Farm Location

    New 2012 “real time” tool (day, week, month, year,…)

    Regular automatic reports in mailbox

    ELISA biochek; ELISA idexx

    Fully Configurable Mapping Tool

  • Geographical Monitoring Tool

    2014 35

    2012 IBD Broilers >35d

  • Geographical Monitoring Tool

    2014 36

    2013 IBD Broilers >35d

  • Geographical Monitoring Tool

    2014 37

    2014* IBD Broilers >35d

  • Geographical Monitoring Tool

    2014 38

    OIE Mapping Tool

    http://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/Diseasedistributionmap

    6 months; Month period; country

    Example: IBD, January to June 2013

    http://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/Diseasedistributionmap

  • Geographical Monitoring Tool

    2014 39

    BIOPORTAL Mapping Tool

    http://bioportal.ucdavis.edu/

    Example: LPAI; Europe

    http://bioportal.ucdavis.edu/

  • Geographical Monitoring Tool

    2014 40

    BIOPORTAL Mapping Tool

    http://bioportal.ucdavis.edu/

    Example: LPAI; Europe; Spain

    http://bioportal.ucdavis.edu/

  • Thank you

    CEVA POULTRY VACCINOLOGIST SUMMIT

    Pablo Catalá Gregori

    DVM, PhD, Dipl. ECPVS

    CECAV - [email protected]

    javascript:self.close()